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INTRODUCTION.
While a great deal has been learned within recent  years regarding
the defensive  reaction  on the part of the body against  foreign  cells
and  foreign  cell  products,  introduced  from without,  our knowledge
of the reactions of the body against  its own  cell  derivatives,  and as
a matter of fact  against its own cells  is as yet very meager.  I use
the expression  " against its own cells "  advisedly, as there is abundant
evidence  to show that the body actually  possesses  forces  which  con-
trol not only normal, but also abnormal  cell proliferation.  In study-
ing  the  protective  mechanism  of  the  animal  body  against  its  own
cells  and cell  derivatives  we  naturally  look  for the same  or similar
methods by which  it reacts  to the introduction  of  foreign  cells,  and
we  may  accordingly  consider  the  possibility  of  auto-phagocytosis
and  auto-antibody  formation.  Both  indeed  seem  to occur.  From
the evidence at hand, however,  it does not appear probable that auto-
phagocytosis  represents  an  important  method  of  defence,  for  in
those cases in which it is observed  the process seems purposeless,  and
rather a secondary  result, the outcome  of some other  process which
itself may  indeed  be  obscured.  I  have thus  noted phagocytosis  of
red  cells by large  mononuclear  leucocytes  in  two  cases  of epidemic
cerebro-spinal  meningitis, where  the corresponding  organisms could
be  directly  demonstrated  in  the  circulating  blood.  In  both  cases
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many  of  the  large  mononuclear  elements  were  engaged  in  the
phagocytosis  of  diplococci  and  one  gained  the  impression  that
the occasional phagocytosis  of red  cells  were  accidental  rather  than
purposeful  (I).
Mary  W.  Rowley  (2)  has  reported  a  remarkable  instance  of  auto-phago-
cytosis  in  a  peculiar case  of  anemia  in  which  all types  of leucocytes  were  found
to  be  phagocytic  for  both  red  and  white  cells,  but  in  which  large  mononuclear
elements  also  seemed  to be  especially  active.  It  is  noteworthy  that  the  addi-
tion  of  the patient's  blood  to  normal  blood  incited  phagocytosis  on  the  part  of
all the  mononuclear  cells  of  the  mixed  blood  and  that  the  subcutaneous  intro-
duction  of a  few  drops  of  the patient's  blood  into a  guinea-pig  after  about  two
weeks led  to  active  phagocytosis  on  the  part  of  approximately  two-thirds  of  all
the  mononuclear  cells.  The  same  writer  has  described  auto-phagocytosis  in  the
blood  of  tertian  malaria  and  chronic  lymphatic  leukemia  (3).  More  recently
Blumenthal  (3a)  has observed the phagocytosis  of both  erythroblasts  and  erythro-
cytes  on  the  part  of  non-granular,  large  mononuclear  leucocytes  in  the  bone
marrow of  adult and  embryonic rabbits.
In  pleuritic  exudates  I  have  repeatedly  observed  the  same  phenomenon  and
was  struck as  in  the other instances  with  the apparently  purposeless  character  of
the process.  The assumption of the presence  of  auto-hemopsonins  does not help
us  in  our  understanding  of  the  process,  and  bearing  in  mind  the  absence  of
phagocytosis  in  other  cases  in  which  active  blood  destruction  is  taking  place,
the formation  of auto-antibodies  in these  exceptional  cases can  hardly be viewed
as  anything  more  than  a  freak  response,  and  hardly  as  a  protective  reaction.
I  do  not  wish  to  convey  the  idea  with this  statement  that  I  regard  the  leuco-
cytes  as  non-essential  in  the  defensive  reaction  of  the  body  against  its  own
cells  and  cell  degeneration  products.  I  am  merely  of the  opinion  that physical
phagocytosis  on  the part of  the  leucocytes  does not play an essential  r61le  during
this  process,  while  I  would  not  deny  their  chemical  cooperation  by  any  means,
even  though there  is  no  direct  proof of  such  action  at the  present time.  Extra-
vascular  phagocytosis,  that  is phagocytosis  occurring  outside  of the blood vessels,
within  the  tissues,  I  would  view  in  the same  light,  viz.,  as  accidental  and pur-
poseless.  This  suggests  itself  at  once  in  connection  with  the  phagocytosis  of
leucocytes,  young  connective  tissue  cells  and  parenchyma  cells  on  the  part  of
cancer  cells.  If  such  pictures  are  to  be  construed  as  evidence  of  a  defensive
reaction  at  all  it must  be  admitted  that  this  reaction  must  be  in  the  nature  of
a defensive  reaction on  the part of  the offending  cell and not of the body  which
is  the  seat  of  the  disease.  In  my  own  studies  I have  never  seen  any  evidence
to suggest that phagocytosis of  cancer cells by the leucocytes  or other cells  of Ihe
body plays  any  r6le of  importance,  and  I think we  may  rightfully  conclude  that
physical  phagocytosis  is  a  negligible  quantity  so  far  as  the  subject  under  dis-
cussion  is  concerned.
As  regards  the  second  method  of  possible  defence,  namely,  by  the production
of  antibodies  directed  against  the  body's  own  cells  and  cell  products,  relatively
little  is  as yet  known.  Some  of  the  reported  findings  lack  confirmation,  and
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of  the  observed  facts.  Referring  to  the  question  of  the  possible  formation
of  autolysins,  Ehrlich  and  Morgenroth  (4),  in  fact,  inclined  to  the  idea  that
this  does  not  take  place  (horror  autotoxicus)  at  all,  and  that  its  occurrence
would  naturaly  lead  to  dire  consequences  for  the  entire  organism.  In  their
experiments  in  this  direction  they  were  able  to  bring  about  the  formation  of
iso-hemolysins,  but  not  of  auto-hemolysins.  While  this  may  be  so  under  rela-
tively  normal  conditions  there  is  some  evidence  to  show  that  in  the  event  of
hemorrhages  into  the  large  cavities  of  the  body  auto-hemolysin  formation  may
after  all  occur,  and  Michaelis  (5)  and  Kober  (6)  interpret  the  hemoglobinuria
which  has  been observed  in  such  cases  in this  sense.  Metalnikoff  (7)  obtained
auto-spermatotoxin  production  in  guinea-pigs  which  had  been  treated  with
their  own  spermatozoa.  Lindemann  (8),  as  the  result  of  his  studies  of  toxic
nephritis,  comes  to  the  conclusion  that  the  nephritic  process  is  due  only  indi-
rectly  to  the  primary  toxic  agent  (chromium  salts,  cantharidin),  but  is  directly
the  outcome  of  the  formation  of  auto-nephrotoxins,  in  consequence  of  the
resorption  of a primary  focus  of  nephritis.  Nefedieff  (9),  Bierry  (o),  Ascoli
and  Figari  (II)  came  to similar  conclusions.  The  former  thus  observed  that
the serum  of  rabbits  in  which  one  ureter had  been  ligated  became  nephrotoxic;
Bierry  noted  the  same  after  ligation  of  the renal  artery,  and  Ascoli  and  Figari
after  a  unilateral  nephrectomy.  Donati  (2)  explained  the  clinical  symptoms
and  pathological  findings  following  unilateral  ligature  of  the  blood-vessel  of
the  kidney  in  rabbits  upon  the  same  basis.
While the reports  of these  observers  sound  quite  convincing,  it is to be  noted
that  the  findings  of  others  have  not  been  in  accord,  and  I  for one  cannot  help
feeling  that  the  term  nephrotoxin  is  used  too  loosely  and  frequently  without
adequate  experimental  basis.  It  does  not  follow  by  any  means  that  the  toxic
agent  or  agents  with  which  these  gentlemen  have  been  dealing  are  true  anti-
bodies,  in  the  sense  of  Ehrlich,  and  with  these  we  are  at  present  concerned.
Pearce  and Sawyer  (3),  while confirming  the  results  of  Lindemann  and Bierry,
viz.,  that  sera  of  dogs  having  nephritis  are  toxic  for  normal  kidneys,  likewise
feel  that the  phenomenon  should  not  be  used  as  a  basis  for the  explanation  of
the  pathology  of nephritis  in  general.
Equally  indefinite  is  our  knowledge  of  the  formation  of  auto-antibodies  in
pregnancy.  Weichardt  (4)  more  especially  attributes  the  occurrence  of
eclampsia to  the  formation  of  auto-syncytiolysins  and  their  effect  upon  syncytial
cells  which  have  entered  the  general  circulation,  an  endotoxemia,  so  to  speak,
resulting.  However  this  may  be,  so  much  seems  to  be  fairly  well  established,
through  the  researches  of  Liepmann  (5),  that  in  pregnancy  placental  con-
stituents  are  actually  demonstrable  in  the  blood  serum.
While  the  preceding  writers  have  directed  their  attention  to  the  existence
of  cytotoxins,  Centanni  (6)  believes  he  has  demonstrated  the  existence  of
auto-precipitins,  referable  to  auto-immunization  with  cell  products.  He  states
that  such  substances  which  he  terms  auto-cytoprecipitins,  are  frequently  en-
countered  in the  sera  of  animals  and of  man  in  various  diseases  and  intoxica-
tions.  He  remarks  that  such  sera  give  rise  to  a  precipitate  already  on  simple
dilution with  normal  salt solution  and that  they are  not specific.  He correlates
auto-precipitation  with  fibrin  formation  on the one  hand  and hetero-precipitation
on the  other, viewing  fibrin  formation  as  a  reaction  of the body  to the products
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of  the  physiological  metabolism  of  its  own  normal  organs,  the  auto-cytopre-
cipitins  as  the reaction  to  the absorption  of products  of its own  diseased organs,
and  the  hetero-precipitins  as  reaction  to  foreign  principles.  Of  special  interest
is  his  observation  that  the  serum  of  sheep  affected  with  hepatic  distomatosis
contains  precipitins  for  extracts  of  normal  liver,  after  partial  autolysis  has
taken  place in  the latter.  Such sera  are  capable  of binding complement  per se,
but  the  fixation  is  more  intense  in  the  simultaneous  presence  of  liver  ex-
tract  (7).
Sabrazes  and  Muratet  (8)  speak  of  the  occurrence  of  auto-agglutination
of  the  red  cells  in  trypanosome  infections,  but  have  made  no  analytical  study
of  the  reaction.  Widal,  Abrami  and  Brule  (Ig)  report  that  they  have  ob-
served  marked  auto-hemagglutination  in  four  cases  of  hemolytic  acholuric
(hematogenic?)  icterus,  and  these  authors,  as  well  as  Worobjeff,  explain  the
symptom  complex  upon  the  basis  of  a  hemolytic  auto-intoxication,  dependent
upon  a primary  "blood  disease."
Liidke  (20)  refers  the  anemia  of  chlorosis  to  the  action  autolysins  derived
from  the  developing  ovaries,  supposing  that the  red  cells  carry  coreceptors  fr
these  bodies,  but  adduces  no  experimental  evidence.
Of  interest  is  the  observation  of  Friedemann  (21)  and  Wohlgemuth  (22),
who  found  that  the  pancreatic  juice  contains  an  auto-hemolysin  which  appar-
ently has the  structure  of  an  amboceptor  and  is  activated  by  means  of  lethicin.
It  is  thus  closely  related  to  the  snake  venom  and  bee  poison  lethicids,2 and
can  accordingly  not  be  viewed  as  an  antibody.  It  is  quite  conceivable  that
under  pathological  conditions  an  auto-hemolytic  effect  might  be  produced  by
such  a  product  and  that  the  serum  of  the  patients  might  possess  hemolytic
properties,  which  accordingly  would  be  erroneously  attributed  to  an  antibody.
As  I  shall  show  later  on,  it  is  important  to  bear  the  possible  formation  of
hemolysins  of  this  order  in  mind  in  connection  with  cell  degeneration  in  gen-
eral.  In  this  connection  it  is interesting  to  note  that  v.  Bergmann  was  able
to  protect  animals  against  the  fatal  consequences  of  pancreatic  auto-digestion
by  previous  immunization  with  pancreatic  material.  Such  protection  might
naturally  be  referred  to  a  corresponding  antibody  formation  and  it  would
suggest  itself  that the same probably would  be  attempted  by the  diseased  animal
itself.  The  proof,  however,  is  lacking.
While  the  above  observers  essentially  deal  with  more  or  less  hypothetical
auto-antibodies  which  are  comparable  to  the  antibodies  which  result  on  im-
munization  with  foreign  cells  and  cell  products,  there  is  a tendency  at  present
to  view  the  complement  fixation  observed  in  syphilis  as  referable  to the  forma-
tion of  auto-antibodies  of  a different  type.  The  nature of the original  technique,
to  be  sure,  would  suggest  that  they  represent  amboceptors,  and  might  hence
after  all  be  comparable  to  or  identical  with  cytotoxins  in  the  sense  of  Ehrlich.
Satisfactory  proof that  such is actually  the  case has, however,  not  been  afforded.
All  the observed  phenomena  connected  with  the process  of  complement  fixation
seem  quite  readily  explained  on  the  basis  of  physical  adsorption,  and  there  is
nothing  to render  necessary  the assumption  of  an amboceptor  nature  on  the part
2 The  term  lethicid  is  here used  in the  sense of  Kyes,  but may  be  inapplicable,
as  suggested  by Bang  (Biochem. Zeit.,  I9o08,  II,  321).
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of  the 'reacting  serum  component.  Accordingly  I  think  it  is  well,  for  the
present  at least, to regard  them as reaction  products  of a  separate  order.  They
may  indeed  be  auto-antibodies,  but  they  are  not  antibodies  directed  against  the
specific  parasite  of  lues.  If  this  view  be  correct  (23),  in  the  case  of  syphilis
then  it would probably  also be  permissible  to  speak  of  auto-antibody  formation
in  other  pathological  conditions  in  which  complement  fixation  has  been  ob-
served  in the  presence  of  various  organ  extracts  as  antigens.  Centanni's  find-
ings  in  sheep  distomatosis  would  thus  fall  under  this order.  The  same  would
hold  good for frambesia, certain  trypanosome  infections  (24)  and  cancer.
I have  pointed  out  in  a previous  paper  (25)  that complement  fixation  is  fre-
quently  observed  in  malignant  disease,  using  cancer  extract  as  antigen,  and  I
expressed  the  hope  at  the  time  that  the  technique  could  be  so  perfected  that
the  method  could  be  used  for  diagnostic  purposes.  This  hope  has  not  been
fulfilled.  We  have  not  been  able  to  demonstrate  fixation  in  more  than  some
sixty  per cent.  of the  cases  and we  have  found  that  syphilitic  cases  react  with
cancer  antigen  and  vice  versa.  It  is  true that  the  fixation  in  cases  of  cancer
is  usually  only  of moderate  intensity  and  often  only  slight,  while the  syphilitic
reaction  is  more  often  absolute;  but  in  syphilis  also  slight  reactions  are  en-
countered  and  in  cancer  they  may  be  likewise  intense.  Our  observations  in
this  direction  have  been  fully  confirmed  by  others,  whose  work  in  part  at least
has  been  synchronous  with  our  own  (26).  While  the  diagnostic  significance
of  complement  fixation  in cancer  is  thus  only  relative,  the principle  involved  is
important  from the  standpoint  of our  present  paper.  If the reaction  in  syphilis
is  due  to the formation  of  auto-antibodies,  the same  undoubtedly  holds  good  for
cancer;  the  differences  which  exist  are  probably  not  qualitative,  but  purely
quantitative.
In  this  connection  I  would  refer  to  the  observation  that  inactivated  sera
may under  various  pathological  conditions  bind complement  per se,  viz.,  in  the
absence  of  any  special  "antigen."  The  phenomenon  was  first  observed  by
Neisser  and  Doering  (27)  in  a  case  of  impending  uremia,  and  has  since  been
studied  by  Neisser  and  Friedemann  (28),  Laqueur  (29),  Hedinger  (30),  Wolze
(3I),  Senator  (32),  Liidke  (33),  Noguchi  (33a),  v.  Bergmann  and  Keuthe  (34),
who  noted  it  in isolated  cases  of  pneumonia,  sepsis,  carcinoma,  leukemia,  uremia,
etc.  We  have  notably  met  with  this  reaction  in  hepatic  cirrhosis,  and  v.  Berg-
mann  and  Salvini  (35)  were  able  to  produce  it  artificially  in  phosplhorous  poisonl-
ing, and  Eva Hoffmann  (36)  in  uremia  and  nephritis.  More  recently  Fiessinger
(37)  reports that  he  could  demonstrate  antibodies  of  this order  in  the  serum  of
patients  with  severe  degenerative  lesions  in  the  liver,  such  as  hepatic  cirrhosis,
with  the  complement  fixation  method,  and  he  views  these,  in  our  estimation
without  proper basis,  as hepatotoxins.  I  am  strongly  tempted  to share  v.  Berg-
mann's  view  that  the  reaction  in  question  is  due  to  an  interaction  between
relatively  large  quantities  of  circulating  degenerative  products  of  body  cells
and  corresponding  auto-antibodies  with  consequent  adsorption  of  complement.
In  conclusion  there  remains  for  consideration  the  possibility  of  an  auto-
antiferment  formation.  Generally  speaking  this  might  be  anticipated  when-
ever  cell  destruction  is  going  on,  since  the intracellular  ferments  must  then  of
necessity  be  liberated.  But  unfortunately  our knowledge  of  these  ferments  is
still  quite  meager  and  the technique  involved  in  their demonstration  sufficiently
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complicated  as  to  render  the  study  of  their  reaction  products,  the  antiferments,
correspondingly  difficult.  A  more  detailed  investigation  of  auto-antiferment
action  has indeed  been  made  only  in  the  case  of  antitrypsin.
Fermi  and  Pernossi  (38),  Camus  and  Gley  (39),  Pugliese  and  Coggi  (40),
as  well  as  Hahn  (4I),  have  demonstrated  that  normal  blood  serum  in  itself
possesses  antitryptic  power.  Other  observers,  such  as  Ascoli  and  Bezzola  (42),
Kolaczek  (43),  Bittorf  (44),  and  Wiens  (45),  then  showed  that  under  patho-
logical  conditions  this  could  be  either  increased  or  diminished,  and  since
Achalme  (46)  had  succeeded  in  immunizing  animals  against  trypsin,  the  con-
clusion  suggested  itself  that  the  increased  antitryptic  action  in  disease  might
well  be  due  to  "antitrypsin."  Ascoli  and  Bezzola's  work  had  reference  essen-
tially  to  pneumonia,  where  they  found  a  marked  increase  up  to  the  time  of
the  crisis,  while  afterwards  coincidently  with  the  disappearance  of  the  local
signs  there  was  a  considerable  decrease.  Kolaczek,  Bittorf  and  Wiens  noted
deviations  from  the  normal  in  various  infectious  diseases.  More  systematic
observations  have  recently  been  recorded  by Brieger  and Trebing  (47).  These
investigators  were  led  to a  more  detailed  study  of  the phenomenon  in  question
by  the  fact  that  they  found  an  increased  antitryptic  content  of  the  serum  in  a
case  of  cancer,  which  remained  constant  during  a  period  of  observation  ex-
tending  over  several  weeks.  They  then  found  that  an  increase  of  antitrypsin
occurs  in  a large  percentage  of  cancer  cases,  namely  in  over  go per  cent.,  and
that  this  increase  may  under  certain  conditions  be  of  diagnostic  importance.
v.  Bergmann  and  Meyer  (48)  confirmed  this  work  with  a  different  method,
but  found,  like  Brieger  and  Trebing,  that  a  similar  increase  may  be  observed
in  some  20  per  cent.  of  non-cancerous  conditions,  such  as  pernicious  anemia,
Basedow's  disease,  severe  nephritis,  sepsis, tabes,  paresis,  etc.  It is  to be noted,
however,  that  the  increase  which  is  observed  in  these  diseases  is  by  no  means
constant,  and  that  with  the  possible  exception  of  pernicious  anemia  and  Base-
dow's  disease,  such  an  increase  is  more  frequently  absent  than 'present.  Dr.
Mary  Roche  (49)  has  recently  collected  the  cases  which  were  examined  in  my
laboratory  during  the  fall  months  and  has  arrived  at  similar  conclusions.
The above  survey  will furnish  an  idea of the  most notable work
which  has  thus  far  been  accomplished  bearing  on  the  problem  of
auto-antibody  formation.  My  own  impression  in going  over  the
work  has  been  that  in  many  instances  the question  may rightfully
be  asked,  whether  the  results  obtained  really  prove  the  point  at
issue,  whether the reactions  which the various observers  have noted
are  really  referable  to  antibodies.  The  whole  question  seems  to
hinge on the definition of the word antibody.  In our usual parlance
we  mean  thereby  certain  reaction  products  which  are  formed  by
the  animal  body as  a  result  of  immunization  with  foreign  cells  or
cell  products.  These  reaction  products  may  be  of  the  nature  of
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ferments.  As  we  have  no  proof  whatever  that  the  substance  or
substances  which  give  rise  to the so-called  Wassermann  reaction  in
syphilis, and  the corresponding  reaction  in cancer, are antibodies  of
this order, we are manifestly not justified in classifying these bodies
as  antibodies  in  the  original  sense  of  the  word.  So  far  as  the
other  anti-reactions  are  concerned  it  is  manifest  that  they  would
more readily fall under the category of antibodies, if we can properly
extend  the definition of the term so as  to  include  reaction products
resulting  upon  immunization  with  the  body's  own  cells  or  cell
products.  This seems in a measure to be justifiable  in view of what
we know of the formation  of iso-antibodies  and some of the experi-
ments recorded above.  In others, the proof has to my mind not been
furnished, and  I feel  more particularly in  connection  with the ques-
tion  of  auto-cytotoxin  production  that  much  more  additional  evi-
dence  is  necessary, before  this  can  be  regarded  as  established.  If
once  established,  however,  we  should  be  forced  to  the  anomalous
conclusion  that  whereas  cytotoxin  production  as  a  result  of  im-
munization  with foreign  cells can be viewed as a defensive  reaction,
auto-cytotoxin  production against  the  body's own cells  would be in
the nature of an offensive  reaction,  a link in a vicious  circle.  This
would  certainly  follow, unless the action  of the auto-cytotoxin pro-
duction  were directed against diseased or otherwise  anomalous  cells,
and not against normal  cells of the  same type; but this view  in turn
would  presuppose  the existence  of specific  receptors  on  the part of
the  diseased  or  anomalous  cells,  which  are  not  possessed  by  the
normal  cells.  Of this  we have  no evidence,  and  it  has  been  noted
more  specifically  in  the  nephrotoxic  experiments  referred  to  above
that  normal cells  were  attacked  by  the  supposed  autotoxin.  As  I
have  said,  it  seems  to me  that  this  question  cannot  be  regarded  as
settled,  and that the  experimental  evidence  is thus far insufficient  to
warrant the recognition of auto-antibodies  of this order.
I  have  reviewed  this  subject  as  outlined  in  order  to show  from
what  sides the  study  of the body's  own defense  against  malignant
disease  may be  attacked  with the likelihood  of making any  definite
progress.  The  only  points  along  these  lines  that  are  definitely
tangible,  and a  further study of which  may lead to fruitful  results,
are  the  increased  antitryptic  content  of  the  blood  serum  and  the
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demonstration  that  in  malignant  disease,  as  in  syphilis,  substances
appear  in  the  blood  which  are  characterized  by  their  increased
affinity  for  complement  in  the  presence  of  certain  organ  extract
constituents.  Research along these lines is still in progress.  In the
present paper, however, we  wish to draw attention  more particularly
to another line of research,  looking  into the body's defences  against
its own cell  onstituents,  which has taken  for its  point of departure
the well known  tendency  on the part of malignant  disease to  lead to
anemia.  Clinical  as  well  as  experimental  evidence  goes  to  show
that  his  tendency  is  largely  independent  of  coincidental  bacterial
infection and referable  to the growing tumor itself.
Panzacchi  (50),  Micheli  and  Donati  (5r),  and  Kullmann  (52)  thus  demon-
strated  that  tumor  extracts  contain  hemolytic  substances,  but  to  Weil  (53)
belongs  the  credit  for  having  shown  that  necrotic  tumors  contain  hemolysins
which differ markedly from those that can  be extracted  from non-necrotic  tumors.
The  latter  apparently  belong  to  the  same  class  of  hemolytic  substances  which
can  be  extracted  from  normal  organs  (liver,  kidney,  pancreas)  and  must  be
viewed  as  complex  hemolysins,  requiring  an  additional  factor  for  their  activa-
tion  which  Weil  found  present  in  extracts  of  normal  red  cells.  The  hemolysins
in  necrotic tumors,  on the other hand, are  apparently  simple hemolysins  requiring
no  additional  "complement"  for their  activation.  Weil  has  suggested  that these
latter  hemolysins  enter  the  blood and  contribute  to  the  anemia  and  the  cachexia
of  malignant  tumors.  In  a  series  of  studies  (54)  the  same  investigator  has
actually  shown  that  hemolysins  are  frequently  present  in  the  blood  serum  of
malignant  disease,  which  can  be  demonstrated  by  allowing  the  cancer  serum  to
act upon  the  red  corpuscles  of  non-cancerous  patients.  Very  curiously,  the  pa-
tient's own  corpuscles,  in vitro at least,  show  an increased  resistance  to their  own
hemolytic  serum.  Crile  (55)  has  come  to  the  same  conclusions  which  Weil
originally  reached  in his  lympho-sarcomatous  dogs, and  seems  to attach consider-
able  importance  to  the  hemolytic  action  of  cancer  serum,  from  the  diagnostic
standpoint,  although  he  finds  the same  reaction  in  cases of tuberculosis.
The work of these  two investigators represents  the starting point
of our  own studies.  It  seems  clear  from  what  has  been  said  that
hemolysins  are  formed  in  malignant  tumors  and  that  these  sub-
stances  enter  the circulation.  There  seems to be  good evidence  of
their  toxic nature  and  the question  hence  suggests  itself:  in  what
manner does  the animal body  attempt its own  defence  against  such
substances?  In  considering  the  possible  lines  of  investigation  in
this direction  the thought  naturally suggested  itself  that even  under
normal  conditions  a  mechanism  might  be  active  which  would  an-
tagonize hemolytic agents, analogous to the normal inhibitory action
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which  normal  blood  serum  possesses  in  reference  to  certain  fer-
ments.  It  was  hence  decided  to  investigate  this  question,  first  in
reference  to  some  non-specific,  general,  hemolyzing  agents,  and
to  extend  the  examinations,  if  evidence  of  a  normal  inhibitory
mechanism  were  found,  so  as  to  include  hemolyzing  agents  of
various kinds,  and among them the tissue and  serum hemolysins  of
cancer,  syphilis  and tuberculosis.  The  first  portion  of  the work  is
embodied  in  the present report.
The general plan of work will appear  from a survey of our initial
studies with saponin.
SAPONIN  EXPERIMENTS.
Serum and  corpuscles  were examined  separately.  In the case  of
the latter, varying amounts of saponin were incubated for 30 minutes
with  constant  quantities  of the  washed  human  corpuscles,  and  the
results then read.  With the serum, varying amounts of saponin were
incubated  for  30 minutes  with  constant  quantities  of  serum,  after
which constant quantities  of corpuscles  were  added.  For conveni-
ence  sake,  washed  chicken  corpuscles  were  uniformly  used  to this
end.  Any  deviations  from  the  normal  could  thus  be  attributed
directly  to  the  human  corpuscles,  on  the  one  hand,  and  to  the
patient's  serum  on  the  other.  The  corpuscles,  both  human  and
those of the chicken,  were washed  three times and then made up into
5 per cent.  emulsions  (corresponding to the full blood,  or as  2.5 per
cent.  emulsions,  corresponding  to the  isolated  red  cells)  in  0.85  per
cent.  saline.  The  serum  was  diluted  in  the  proportion  of  I  in  io
with saline.
Two  strengths  of  saponin  were  employed.  The  one  solution,  A,  represcls
a  o.I  per  cent.  solution  in  o.85  per  cent.  saline,  while  the  second,  B,  reprecsellts
a  in  o  dilution  of  A.  Series  of  tubes  were  charged  with  varying  amounts  of
these  solutions  and  the  volume  was  always  brought  to  I  c.c.  with  saline,  after
which the human  corpuscles  were  added  in the  one  series,  and  the  diluted  human
sera  in the other,  0.5  c.c.  of either  being the constant amount  of these,  as  also  of
the chicken  corpuscles,  as described  above.  Preliminary experiments  with normal
human  corpuscles  showed  that  o.I  c.c.  of  the  B  solution  (B-I)  of  saponin  will
rarely  hemolyze  0.5  c.c.  of  normal  corpuscles;  as  a  rule,  there  is not  a  trace  of
hemolysis  with this  concentration.  In  many  normal  instances  the  same  is  seen
in  tube  B-2;  but  in  others  there  is  more  or  less  extensive  hemolysis.  Beyond
this, namely,  in  B-3,  and  B-4,  etc.,  there  is complete  hemolysis.
With  normal  sera  no  hemolysis  is  usually  obtained  in  either  B-9 or  in  A-I;
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occasionally  A-i  shows  more  or  less extensive  hemolysis,  but  this  is  the  excep-
tion.  Beyond  A-i  there  is  complete  hemolysis.  Hence  for  routine  work  it  is
necessary  only  to  put  up  tubes  B-I  to  B-4  for  the  corpuscles  and  B-9  to  A-4
for  the  serum.
An experiment  of this order  is recorded below.  It is to be noted
that  in  this  particular  instance  the corpuscle  experiment  in  contra-
distinction to the serum experiment,  has reference  not to human red
cells,  but to those  of the chicken.  This  will  show  very  clearly  the
marked protective power on the part of the blood serum, as the range
between  corpuscle  hemolysis  and  serum-corpuscle  hemolysis  is even
wider than in the case of the  human red cells.
1.  II.
Serum.  Corpuscles.
A-3  Hemolysis  Hemolysis
A-2  Hemolysis  Hemolysis
A-I  Inhibition  Hemolysis
B-9  Inhibition  Hemolysis
B-8  Inhibition  Hemolysis
B-7  Inhibition  Hemolysis
B-6  Inhibition  Hemolysis
B-5  Inhibition  Hemolysis
B-4  Inhibition  Hemolysis
B-3  Inhibition  Hemolysis
B-2  Inhibition  Hemolysis
B-I  Inhibition  Hemolysis
C-9  Inhibition  No  hemolysis
C-8  Inhibition  No  hemolysis
Up to the  present time we have examined  the sera and corpuscles
of some  200  cases,  including  a number  of supposedly  normal  indi-
viduals.  The list covers  a fairly wide range  of pathological  condi-
tions,  as  is apparent  from  the  accompanying  tables,  in  which  the
cases  are  arranged  in  four groups.  Group  I  includes  those  cases
which  showed  no  hemolysis  in  either B-9  or  A-I  (corresponding
to  o.oooog  and  o.oooI  gm.  of  saponin  respectively).  Group  II
covers  those  which  showed  no  hemolysis  in  B- 9,  but  a  variable
degree of hemolysis in A-I.  In Group III those cases  are collected
in  which  hemolysis  occurred  in  both  A-I  and  B-9.  Group  IV
finally represents  a  small  number  of  cases  in  which  no  hemolysis
occurred  in  either  B-9, A-I,  A-2,  or  still  stronger  solutions  of
saponin.
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We interpret our findings by inferring  in Group I that the sera of
the  cases  collected  under  this  heading have  the  same antihemolytic
power  as  is  observed  under  strictly  normal  conditions,  while  in
Group  II  this  is less;  in Group  III, still less; and  in  Group IV,  in-
creased.  Most  of  the  normal  cases  fell  under  Group  I,  while  a
smaller percentage  is to be found in Group II.  We have never  seen
a  single instance  where  a  normal  individual  showed  a  decrease  in
the  antihemolytic  power  of  such extent as  to fall  under  Group III.
We  have  similarly  never  observed  a  material  increase  extending
beyond A-I;  occasionally  A-2  is  not  completely  hemolyzed,  but  a
more marked  inhibition does not occur.
The  following  Table  I gives  a  summary  of  our  cases  arranged
under  the  heading  of  the  different  diseases;  the  results  show  the
number  of cases  examined  and the percentage  values  for hemolysis
at various  concentrations  of the saponin solution.
TABLE  I.
I.  II  III.  IV.
Hemolysis  Inhibit.  Inhibit.  Inhibit.
Total  in  B- 9 and  in B-9  in  and  beyond
no. of  upward.  only  A-.  A-.
cases.
No.  of  Per  No. of  Per  No. of  Per  No.  of  Per
cases.  cent.  cases.  cent.  cases.  cent.  cases.  cent.
Normal cases ...............................  24  o  o  7  29  17  71
Malignant tumors  . .......................... 15  3  20  6  40  6  40
Non-malignant  tumors ....................  5  I  20  2  40  2  40
Appendicitis .................................  I  --  I  loo
Pernicious anemia ..........................  I  - I  zoo
Syphilis................................  15  12  80  2  12  I  8
Tabes.........................................  2  2  1oo
Syphilitic mental  cases ...................  3  3  100  0
Non-syphilitic mental cases ..............  to  0o  loo
Tuberculosis .................................  go  51  56  19  21  20  23
Chancroid ....................................  I  I  Ioo
Multiple sclerosis...........................  I  ioo  I  1oo
Apoplexy ....................................  I
Ulcer of the  stomach ......................  4  2  50  2  50  100
Arteriosclerosis  ..............................  I
Neuroses .................... oo............  I  I  00
Gonococcus  infections.....................  3  I  33  2  66
Chronic arthritis...........................  1  I  o00
Staphylococcus  infections .................  I  I  oo
Streptococcus  infections ...................  I  I  Ioo
Pernicious vomiting of pregnancy......  I  I  1oo
Cholelithinsis ............  ....  ..............  4  4
Strongyloides  infection ....................  I  1o0
Carbon monoxide poisoning ..............  I  I  ooAuto-antibody Formation and Antihemolysis.
The behavior  of the pathological  sera  was  most interesting.  As
a  glance  at the  table above  will  show,  a deviation  from  the normal
was  observed in  only three  of the cancer  cases,  and in  one of these
a history  of syphilis could not be excluded.  This means, of course,
that  so  far as  saponin  is  concerned  the antihemolytic  power  of the
blood  serum  is  neither  materially  increased  nor  diminished.  It
might be argued that this observation has no direct bearing upon the
question  of  the  antihemolytic  protective  mechanism  in  malignant
disease, and that in cancer  a more specific protective  mechanism may
be  brought  into  play,  which  would  be  tuned  to  specific  cancer
hemolysins.  This  is,  of  course,  quite  conceivable  and  the  problem
was accordingly put to the direct test as will be discussed  more fully
later on.
Quite  interesting  further  is  the  observation  that  in  pernicious
anemia  no  evidence  of  either  an  increased  or  a  diminished  anti-
hemolytic  power  was  obtained,  which  also could  be  interpreted  as
merely  showing that no change in the antihemolytic action exists  so
far  as  saponin  is  concerned.  We  will  have  occasion  to  revert  to
this question on a future  occasion.
The  most  remarkable  result  in this  series  of  observations  was
obtained  in  cases  of  syphilis  and  tuberculosis.  As  a  glance  at
Column  I  will  show,  hemolysis  in  B- 9 was  obtained  with  few
exceptions  in  these  two  diseases  only.  In  interpreting  the  result,
two  possibilities  suggested  themselves:  on  the  one  hand,  it  was
possible  that  the  increased  tendency  to  hemolysis  by saponin  was
due  to a diminution  in  the amount  of antihemolytic  substance,  and
on  the other, that the  diminished  antihemolytic  effect  was in reality
due, not to a negative, but to a positive  factor, that is, to the presence
of hemolysins  in the blood  serum of the patient, the effect of  which
would be obtained either  independently  or superadded  to the  action
of  the  saponin.  The  second  possibility  suggests  itself  directly
since  Crile  (56)  reports  that the  blood serum  of  tuberculosis  may
be  hemolytic  for  normal  corpuscles,  while  Peskind  (57)  has
demonstrated  the same  for syphilis.  We  found, however,  that this
explanation  is  not. applicable  in  the  present  instance.  We  could
demonstrate by suitable controls that with  rare exceptions  and  with
the  degree  of  dilution  which  we  employed  tubercular  sera  do  not
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possess  any  hemolytic  action  whatever  upon  chicken  corpuscles.
Very rarely only does one see a very  faint pink in  these controls,  and
it  is  noteworthy  that  this  occurred  at  times  even  though  the  cor-
responding B-9  saponin  tube  showed  no  trace  whatever  of  hemo-
lysis.  Our results  in  this  respect  are  so striking  that  we have  not
the  least  hesitancy  in  affirming  that  the  marked  hemolysis  in  the
B-9  tubes  cannot  possibly  be  due  to  the  action  of  a  tubercular
hemolysin,  acting either independently  or in  addition to  the saponin
effect.  We  believe  that the  conclusion  is  warrantable that  the  in-
creased  hemolytic  effect  with  saponin,  which  is  so  frequently  ob-
served  in  tuberculosis,  must be  referable  to  a decrease  in  the  anti-
hemolytic  components  of  the  blood  serum.  We  have  reason  to
think that the same holds good for syphilis.
While  any inferences  that may be  drawn from  these experiments
apply for the present at least to the mechanism of saponin hemolysis
only,  the  results  seem  to  be  important  in  principle.  They  show
quite clearly that a certain type of anemia may be referable primarily
to  a  diminution  in the quantity  of  a normal  protective  agent,  and
only indirectly  to the  effect  of  the hemolysin  upon  the  corpuscles.
This  protective  power  is  indeed  very  considerable,  if  we  bear  in
mind that our results were obtained with sera which had been diluted
tenfold  at the  start,  and  further  diluted  by the  addition  of  double
the volume  of the  saponin  solution.  It is  true that  our sera  were
usually  tested  only  against  a  5  per  cent.  emulsion  of  corpuscles,
but  we  could  show  that  its  protective  action,  even  in  the  dilution
which we employed,  was  in reality  of a much  wider  scope.
CHARACTERISTICS  OF  THE  ANTIIIEMOLYTIC  SUBSTANCE.
Regarding the nature  of the  antihemolytic  substance,  the follow-
ing data were obtained.
Heating  experiments  showed  that  exposure  of  normal  human
serum  for 30  minutes at  520  C.  does  not interfere  with its  normal
antihemolytic  action  so  far as saponin hemolysis  goes.
The  following experiments were  undertaken  to ascertain  the part
which the proteins of the serum take  in the antihemolytic  action  of
the blood  serum.  The material used was  the pleural exudate  from
a  tubercular  patient  (Sch.)  which  in  its  original  condition  gave
absolute  inhibition  in  B-9 and  almost  complete  hemolysis  in  A-i.
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50  c.c.  of  this  serum  after  careful  centrifugalization,  were  treated  with  50
c.c.  of  a  neutral  saturated  solution  of  ammonium  sulphate  and  the  precipitated
globulins  were  filtered  off the next  day.  The  filtrate,  when brought to the proper
dilution  and  sodium  chloride  concentration  showed  no  manifest  antihemolytic
effect  whatever,  from  A-5  to  B-7.  In  B-6  yet  there  was  very  extensive
hemolysis  and  in B-5  even there  remained  a  large  cup  of undissolved  red  cells.
I  am  nevertheless  inclined  to think  that  underlying  this  apparent
lack  of  antihemolysis  there  is  still  an  antihemolytic  effect,  since
control  experiments  with  corresponding  amounts  of  ammonium
sulphate  in  saline,  with  even  lower  amounts  of  saponin,  showed
instantaneous  hemolysis,  whereas  the  hemolytic  action  in  the pres-
ence  of the  filtrate  took  place  gradually  on  incubation.  F.  Sachs
(58)  has  recently  observed  that  soap  hemolysis  will  occur  instan-
taneously  in  the  presence  of  OH  ions,  but  he  remarks  that  with
saponin  the  phenomenon  was  only  suggestive  and  then  only  when
sodium  hydrate  had  been  used.  Our  experience  with  ammonium
sulphate  shows  that  it  occurs  instantaneously,  while  the  same  salt
without  the saponin  causes  no  hemolysis  whatever  during  the  time
limit  (30  minutes)  that  we  allowed  our preparations  to  remain  in
the  incubator.  Bearing  this  effect  in  mind,  our  conclusion,  that
the  filtrate  from  which  the  globulins  have  been  removed,  has
still  a  certain  degree  of  antihemolytic  action,  does  not  seem  un-
warrantable.  However,  we  have  not  followed  up  this  point  any
further.
The  globulin  fracton  was  next  tested,  after  bringing  it  to  the
proper  degree  of  dilution  and  sodium  chloride  concentration.  It
was  found  that with  B-9  and A-I  there  was  complete  inhibition,
partial  inhibition  in A-2  and  complete  hemolysis  only  in A- 3. It
would  thus  seem  as  though  almost  the  entire  antihemolytic  effect
were  centered  in  the  globulin  precipitate.  To  ascertain  to  what
extent the eu- and the pseudoglobulin  fractions are concerned  in the
question,  the  entire  globulin  precipitate,  dissolved  in  saline,  was
dialyzed against  running water  for twenty-four  hours,  and the two
portions tested, after bringing them to the proper  degree of dilution
and sodium chloride  concentration.  It was  found  that  the  euglob-
ulin  fraction  had  lost  much  of  the  original  antihemolytic  action,
as complete  hemolysis  was  obtained  not  only  in  A-I  and  B-9, but
extensive hemolysis  was yet obtained  with B-8 and B-7; a complete
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antihemolytic  effect  was  not obtained  until B-5 was  reached.  Ex-
amination  of  the  pseudoglobulin  fraction  showed  a  corresponding
loss  even  exceeding  that  of  the  former;  complete  hemolysis  was
obtained  as  far  down  as  B-7,  and  even  in  B- 5 it  was  extensive.
The  impression  was  thus gained  that  the  antihemolytic  substance
had  either disappeared  or become  inactive.  That  the time  element
plays  no  role  at  this  point  is clear  from  the  fact that  sera  can  be
preserved  much longer  and still  retain their antihemolytic  action.
In order to ascertain  whether  the cholesterin of  the blood  serum
might  be  responsible  for the antihemolytic  effect,  one  set  of  tubes
was charged  as usual with serum and saponin plus an extra  volume
of  saline,  while  the  second  set  received  corresponding  amounts  of
the same serum with saponin, and in place of the saline,  one volume
of  an  emulsion  of  cholesterin  in  saline,  which  had  been  centri-
fugalized  as  free  from  cholesterin  in  suspension  as possible.  The
result  is  seen  below:
1.  II.
Serum-Saline-Saponin.  Serum-Cholesterin-Saponin.
B-9  Inhibition  (absolute).  Absolute  inhibition.
A-I  Inhibition  (absolute).  Absolute  inhibition.
A-2  Almost complete  hemolysis.  Absolute  inhibition.
A-3  Almost complete  hemolysis.  Partial  hemolysis.
It is thus evident that cholesterin,  even  in minute doses, is capable
of increasing  the antihemolytic action  of normal  blood  serum quite
materially, and it is noteworthy that the  same effect is obtained  with
cholesterin  in  the  absence  of  serum,  as  is  shown  in  the  following
experiment:
1.  11.
Corpuscles-Saline-Saponin.  Corpuscles-Cholestcrin-Siponiln.
B-5  Practically  complete  hemolysis.  Extensive  inhibition.
B-6  Complete  hemolysis.  Extensive  inhibition.
B-7  Complete  hemolysis.  Extensive  inhibition.
B-8  Complete  hemolysis.  Fair  Inhibition.
B-9  Complete  hemolysis.  Slight  inhibition.
A-I  Complete  hemolysis.  Hemolysis  complete.
A-2  Complete  hemolysis.  Hemolysis  complete.
Our  results  in  this  respect  are  thus  in perfect  accord with  those
of  Ransom  (59),  who,  already  in  I9OI,  noted  the  antihemolytic
action  of cholesterin  toward saponin,  but he  does not seem  to have
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utilized the principle involved in the study of the protective mechan-
ism of the animal body in disease.
It would of  course be tempting to follow  up this  line of  investi-
gation  by  corresponding  studies  on  the  cholesterin  content  of  the
blood  serum  in  syphilis  and  tuberculosis.  But  for the  present  we
were  obliged  to content ourselves  with the mere  recognition  of the
possibility  that  the  decreased  antihemolytic  content  of  the  blood
serum  in  the  two  diseases  mentioned  may  be  due  to a  decrease  in
the  cholesterin  content,  and  that  our  saponin-hemolysis  technique
may  constitute  a  convenient  method  for estimating  that  component
in  the blood  serum.  A direct  investigation of this  question  is  now
in progress.
So far as our present experience goes it would seem that a diminu-
tion  in  the  cholesterin  content  of  the  blood  serum  of  tubercular
patients  is  principally observed  in  actively  progressing  cases,  while
in  mild cases  and early  lesions  normal  values  are usually  obtained.
We  could  thus  note  that  among  sanatorium  patients  who  were
confined  to bed  a decrease  in the antihemolytic  power  of the serum
was  observed  in nearly every case,  while  among those  who were up
and  about  normal  values  were  frequently  found.  Interesting
further  is  the  observation  that  the  injection  of  tuberculin  per se
does  not  appear  to  affect  the  antihemolytic  power  of  the  serum
at  all.  The  actual  significance  of  the  phenomenon  still  remains
to be elicited, and, for the present  at least, we should  like very much
to  reserve  this problem  for our  own investigation.
In  syphilis  also  we  have  found  that  a  lowered  antihemolytic
action of the serum  is essentially  observed  in active  cases,  in which
a  positive  Wassermann  reaction  can  be  obtained.  On  this  point
also we wish to report  in detail on some  future occasion.
If  now  we  turn  our attention  to the  behavior  of  the  corpuscles
toward  saponin,  we  find  that,  unprotected  by  serum,  they  are
hemolyzed  very  readily  even  under  normal  conditions  by  much
smaller  amounts  of  the  reagent.  In  50  per  cent.  of  the  controls
partial  hemolysis,  at least,  occurred  already  in  the B-2  tube,  cor-
responding  to  0.00002  gm.  of  saponin  to  I25,0oo0,o000o  red  cells.
Even  in  the B-I  group there  are  a  few  normal  individuals,  while
only  30 per  cent.  have  corpuscles  which  resist the  saponin  of  B-2
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altogether.  Beyond  this  we  have  never  seen  resistance  in  normal
individuals.
So  far as  pathological  conditions  are  concerned,  we have  found
no  constant  deviations  from  the normal  values  in  any  one disease.
No  increased  resistance  toward  saponin  is  noticeable  in  those  two
diseases,  more  especially  where  increased  resistance  has  been  ob-
served  toward  the  respective  hemolytic  sera,  viz.,  in  cancer  and
syphilis  (Crile  and  Peskind).  If  there  be  any  tendency  at  all
toward  a deviation  from the  normal, it is  certainly in the direction
of increased vulnerability,  and not the reverse.  This observation,  as
also  the  fact that  the  corpuscles  in  tubercular  patients  and  of  the
single case of pernicious  anemia  (which  was  very severe)  show no
essential  deviation  from  the  normal,  we  would  emphasize  more
particularly,  as  it seems  quite important  in  principle.
TOLUOL  HEMOLYSIS.
For workers  with organ extracts  it  is  important to bear  in mind
that toluol,  which is  so extensively used as  a preservative,  has very
decided  hemolytic  properties.  We  found  that  the  solubility  of
toluol  in  saline  is  such  that  0.5  c.c.  of  the  saturated  solution  will
bring  about  the  complete  hemolysis  of  0.5  c.c.  of  a  5  per  cent.
emulsion of  chicken corpuscles  within  30 minutes,  at 370  C.
Agents  in  which  toluol  is  more  readily  soluble, and  which  them-
selves  are soluble  in saline,  bring about  a corresponding  increase  in
the degree  of  hemolysis.  Alcohol  acts  in  this  manner.  For this
reason  an  alcoholic  extract  of  an organ,  containing toluol,  is  more
strongly  hemolytic  than  a  corresponding  saline  extract.  Working
with  both  saline  and  alcoholic  extracts,  which  per se  were  not
hemolytic,  but in  which  the  presence  of  hemolysins  was  simulated
by the  toluol,  we  found  that  as  in  saponin  hemolysin  blood  serum
exercised  a marked  antihemolytic  effect.
We have  studied  55  sera  from  different  diseases,  and  corpuscles
from  25  cases,  in  their  behavior  toward  toluol  as  an  hemolytic
agent, but have been unable to observe any differences  worth noting,
as compared  with the normal.
So far as the nature of the antihemolytic component of the serum
is  concerned,  we  have  ascertained  that  the  inhibitory  substance  is
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precipitated  with the globulins  on salting with ammonium  sulphate,
and that the inhibitory  action of both  the euglobulin and  the pseudo-
globulin  fraction  is  practically  alike.  Cholesterin  plays  no  role  in
the  process.
SOAP  HEMOLYSIS.
Soap was chosen as the next hemolytic agent, because  its universal
presence  in  the  fluids  and  tissues  of  the body  renders  it  especially
important  as  a  possible  factor  in  the  production  of  anemia.
Through the researches  of Noguchi  (60) and v.  Liebermann  (6i),
working independently  of one another,  it was  first  shown  that the
blood  serum  is  capable  of inhibiting  the hemolytic  action  of  soaps,
and  that their  innocuous  existence  in  the  blood  in  concentrations
which  in vitro would  be  sufficient  to  cause  hemolysis,  is  no  doubt
dependent upon the antihemolytic  action of the blood serum.  As  it
is a priori not impossible that  this antihemolytic  mechanism may  in
disease be more or less seriously impeded, it would follow that under
pathological  conditions  soap  hemolysis  might actually  take place  in
the  body,  and that  by  suitable  experiments  it  should be  possible  to
demonstrate  deviations  in  the  antihemolytic  action  of  the  serum.
To this  end we  have investigated  the effect of the  serum upon soap
hemolysis  in a  fairly  large  number  of the more  important  diseases,
directing our attention  more  particularly to cancer,  tuberculosis  and
syphilis.
As  in  our saponin  experiments,  we  first  ascertained  the  concen-
tration of the  soap  solution  in  which  complete  hemolysis  of a con-
stant  quantity  of  washed  red  corpuscles  will occur.  Subsequently
it  was determined  to what extent  the concentration  of the soap solu-
tion  must  be  increased  in  order  to  bring  about  hemolysis  of  the
same  quantity of  red cells  in the  presence  of constant  quantities  of
normal  blood  serum.  After  this,  pathological  sera  were  similarly
examined.
For  routine  work  we  employed  a  0.5  per  cent.  solution  of  sodium  oleate  in
o.85  per cent.  saline  solution.  The sera  were  diluted  I: Io, and as  in  our saponin
work  we  used  a  5 per  cent.  emulsion  of  thrice-washed  chicken  corpuscles.  Our
soap  was  the  neutral  sodium  oleate  marketed  by  Merck.  The  general  arrange-
ment of  the  experiments,  the hemolytic  power of  the soap  and  the antihemolytic
effect  of  normal  blood  serum  is shown  in  the  following  scheme:
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I.  Corpuscle Hentolysis.
Soap  solution.  Saline.  Corpuscles.  ieult after3o  minutes
0.I C.C.  .9 c.c.  0o.5 c.c.  No  hemolysis.
0.2  c.c.  o.8 c.c.  0.5 c.c.  No  hcmolysis.
0.3 c.c.  0.7 c.c.  0o.5 c.c.  Complete  hemolysis.
0.4 c.c.  o.6 c.c.  0.5 c.c.  Complete  hemolysis.
0.5 c.c.  0.5 c..  0.5 c.c.  Complete  hemolysis.
II.  Serum  Hemolysis.
Soap  solution.  Saline.  Serum.  Corpuscles.  Result after  30 further minutes  of  ncubation.
o.I  C.C.  0.9 c.c.  0.5 c.c.  0o.5  Inhibition.
0.2 C.C.  o.8 c.c.  0.5 C.C.  0.5  Inhibition.
0.3 c.c.  0.7 c.c.  0.5 c.c.  o.5  Inhibition.
0.4 c.c.  o.6 c.c.  0o.5 c.c.  o.5  Inhibition.
0.5 c.c.  0o.5 c.c.  0.5 c.c.  0.5  Marked  hemolysis.
0.6 c.c.  0.4 c.c.  0.5 c.c.  0.5  Complete  hemolysis.
0.7 c.c.  0.3 c.c.  0.5 c.c.  0.5  Complete  hemolysis.
In this connection it may not be out of place  to refer to an obser-
vation  which  we  made  in  the  course  of  our  experiments,  which
caused  us  a  great deal  of  annoyance  for a  while.  We  obtained  a
neutral  sodium  oleate  preparation  from  a  local  dealer,  which  at
first showed perfectly normal behavior, hemolyzing quite readily and
being inhibited by the addition of serum.  After a few  weeks, how-
ever,  it lost  its  hemolytic  power entirely,  so that  the substance  be-
came perfectly useless for hemolytic  experiments.  Chemical investi-
gation showed  that our neutral  oleate  had been transformed  almost
entirely  into  the  oxy-salt.  This  possibility  will  have  to  be  con-
sidered  in the  future  in experiments  in which  an inhibitory effect  is
noted.
Regarding  the  manner  in  which  sodium  oleate  brings  about
hemolysis,  and  in  which  blood  serum  inhibits  this  action,  we  would
offer the  following tentative  explanation.  While concentrated  solu-
tions  of the oleate  are  actually  neutral  so  far as phenolphthalein  is
concerned,  solutions  of such strength as are generally used in hemo-
lytic work present a markedly alkaline reaction.  This change can be
readily observed  on diluting a concentrated  solution  to which a drop
or two of phenolphthalein has been added and in which no color can
be  discerned,  when  from  a  certain  point  off  the  red  color  of  the
sodium salt  of phenolphthalein  develops.  On  dilution  of  the  soap
we  thus observe  a  hydrolytic  dissociation  leading  to  the  liberation
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of  oleic  acid  on  the  one hand  and  caustic  alkali  on  the  other.  In
view of the fact that oleic acid  is hemolytic per se and that hydroxyl
ions, as I have shown before, may act as a katalysing agent, it would
not  appear  far-fetched  to  explain  soap hemolysis  in dilute  solution
upon  this basis.  Hemolysis,  it  is true,  will  also  be brought  about
by concentrated  solutions of soap, in  which this dissociation  has not
occurred, but  is seems to me that the two conditions are not directly
comparable,  and that the hemolytic  effect  of concentrated  solutions
may very well be due to absorption of water from the red corpuscles.
If  our  view  regarding  soap  hemolysis  in  dilute  solutions  should
prove to be correct,  it would suggest  itself that the inhibitory action
of the  blood  serum  could  very well  be  due  to  a  neutralizing  effect
of the albumins acting  as acids upon the liberated alkali.  We offer
this explanation merely as a tentative  one  at this time and expect  to
report  upon the question  in  some detail  in a  separate  paper.
Our  findings,  so  far  as  the  antihemolytic  action  of  the  blood
serum in disease is concerned,  are collected  in the following Table II.
TABLE  II.
Showing  the  extent  of  the  antihemolytic power  of  the  blood  serum  under
various pathological  conditions.  The  figures  have reference to  the concentration
of the soap solution at which  the antihemolytic effect of the serum (diluted I:  o)
is first overcome  (see  example above).
Hemolysis  begins at  Hemolysis  begins  at
Total no.  0.4 CC.  0.5 C.C. 
of  cases.  No.  of  Per cent.  No.  of  Per cent.
cases.  cases.
Normal  cases  .......................  19  37  12  63
Malignant  disease.  .............  ........  1  7  63  4  36
Tuberculosis ............................  20  18  go  2  17
Syphilis...................................  6  17  5  93
Septic infections ......... ..............  75  x  25
Cholelithiasis ............................  4  2  50  2  50
Measles ...  ......... ...............  I  I  oo
Bone  injuries .......................  4  3  75  25
Pneumonia  ............................  2  I  50  I  50
Cirrhosis of  the liver ..................  3  I  33  2  66
Strongyloides  infection ...............  I  I  Ioo
Osteomyelitis ............................  I  I  oo
Bronchitis .................................  I  I  00
Neurasthenia  ............................  2  2  100
Typhoid fever ...........................  I  I  100
Gonorrheal  infections ..................  I  I  1oo
Pyelitis  (calculous) .....................  I  I  oo
Nephritis .............................  I  I  Ioo
Sciatica ............  .......................  I  oo
Non-syphilitic  mental  cases ..........  5  5  ooCharles E.  Simon,  Elizabeth  Melvin  and Mary  Roche.
An  analysis  of  this  table  shows  that  whereas  the  majority  of
normal sera are capable of counteracting  the hemolytic action of the
soap solution up to 0.5  cubic centimeters,  there  are some individuals
in  which  the  antihemolytic  power  even  normally  does  not  extend
beyond  0o.3;  hemolysis  in  some  of  these  may  indeed  be  complete
at 0.4.
So  far  as  the  behavior  of  the  sera  in  disease  is  concerned,  it
would  appear  that  there  is  a  decrease  of  the  antihemolytic  action
under  the  most  divers  pathological  conditions.  It  would  hardly
seem  justifiable,  however,  to  conclude  that  the  anemia  which  may
be an  accompanying  factor  in  some  of  these  conditions  is  due  to
spontaneous  soap  hemolysis  taking  place  in the  body,  as  the  same
decrease  may be  observed  in  conditions  in  which  no  anemia  at  all
is  noticeable.  We  rather  incline  to  the  belief  that  the  relatively
slight  deviation  from  the  average  normal  values  may  be  due  to
slight variations in the anion and kation content of the blood serum,
and  hence  constitute  an  expression  of  the alkalinity  of  the  blood.
It follows  that in the  diseases  which  have been  studied  there is  no
evidence  of a  special defensive  reaction  on the part  of the body  so
far as hemolytic agents of this order are concerned.
While our table shows that there is a decrease  in the antihemolytic
power of the blood serum in various pathological conditions, it is evi-
dent also that this is inconstant and cannot be utilized  for diagnostic
purposes.  It is  noteworthy  nevertheless  that  in the  case  of  soap
hemolysis  also  a  marked  decrease  in  the  antihemolytic  power  of
the serum  is  demonstrable  in a  large  proportion  (90  per  cent.)  of
the tubercular cases,  and it would seem  of interest to follow  this  up
in a further study.  In syphilis,  on the other hand, normal  relations
are  encountered.
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